Results 81 to 90 of about 4,373 (200)

Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.

, 1991
Serial muscle biopsies in a noncarcinomatous case of Lambert-Eaton myasthenic syndrome (LEMS) have shown progressive atrophy and loss of type 1 fibers, resulting in overwhelming type 2 predominance. A similar abnormality was found in a single biopsy from
Hilton-Jones, David, Squier, M, Chalk, C, Mills, KR, Newsom-Davis, J, Hilton-Jones, D   +5 more
core   +1 more source

Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period

Chinese Journal of Cancer, 2016
Lambert–Eaton myasthenic syndrome (LEMS) is a paraneoplastic syndrome and only 3% of small cell lung carcinoma (SCLC) patients have LEMS. Moreover, the recurrence of SCLC after a disease-free survival (DFS) of more than 10 years is rare.
Fumio Asano, Keisuke Watanabe, Masaharu Shinkai, Yoshitaka Tei, Kei Mishina, Mikiko Tanabe, Hiroshi Ishii, Masahiro Shinoda, Tadasuke Shimokawaji, Makoto Kudo, Takeshi Kaneko   +10 more
doaj   +1 more source

Idiopathic Lambert-Eaton myasthenic syndrome. Report of one case [PDF]

, 2006
Lambert-Eaton myasthenic syndrome (LEMS) is an autoinmune idiopathic or paraneoplastic syndrome producing antibodies agaisnt presynaptic voltage calcium channels.
Idiáquez C., Juan, Delgado M., Marcela, Pedraza C., Luis, Guevara O., Carlos   +3 more
core  

Transient Lambert-Eaton myasthenic syndrome associated with systemic lupus erythematosus [PDF]

, 1989
We present a patient who developed the Lambert–Eaton myasthenic syndrome (LEMS) in association with systemic lupus erythematosus (SLE). Severe proximal weakness with electrodiagnostic evidence of LEMS developed over 2 days during an exacerbation of ...
Albers, James W., McCune, William Joseph, Bromberg, Mark B.   +2 more
core   +1 more source

Electrophysiological and muscle pathological characteristics of Lambert - Eaton myasthenic syndrome

Chinese Journal of Contemporary Neurology and Neurosurgery
Objective To summarize the electrophysiological and muscle pathological characteristics of Lambert - Eaton myasthenic syndrome (LEMS). Methods and Results Twelve LEMS patients referred to China - Japan Friendship Hospital between January 2010 and ...
SUN Qing, JIAO Jin-song, SUN Shao-jie, WANG Wei, PENG Dan-tao, WANG Ren-bin   +5 more
doaj   +1 more source

Lambert-Eaton myasthenic syndrome associated with intravascular uterine leiomyoma.

, 2011
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune neurologic disease with impaired transmission across neuromuscular junction, and . LEMS is thought to be caused by antibodies directed against presynaptic P/Q-type voltage-gated calcium channels ...
Ariatti A, Agnoletto V, Galassi G, RIVASI, Francesco   +3 more
core   +1 more source

Diagnosis and treatment of paraneoplastic neurological disorders [PDF]

, 2004
In about two thirds of cases, patients with paraneoplastic neurological disorders present to the neurologist without a known tumor. Due to the ongoing immune response, this tumor tends to stay biologically relatively benign, and therefore difficult to ...
Voltz, R., Graus, F.
core   +1 more source

Lambert-Eaton myasthenic syndrome – a misdiagnosed condition [PDF]

, 2019
Background: Lambert-Eaton myasthenic syndrome (LEMS) is a rare disorder of the neuromuscular junction. Clinical features include proximal muscle weakness, markedly in the lower limbs, reduced deep tendon reflexes that can increase after exercise, and ...
Sangheli, Marina, Fala, Paula, Chetrari, Larisa, Gavriliuc, Pavel, Cojocaru, Ina, Lisnic, Vitalie   +5 more
core   +1 more source

Autoantibodies in neuromuscular disorders: a review of their utility in clinical practice

Frontiers in Neurology
A great proportion of neuromuscular diseases are immune-mediated, included myasthenia gravis, Lambert-Eaton myasthenic syndrome, acute- and chronic-onset autoimmune neuropathies (anti-MAG neuropathy, multifocal motor neuropathy, Guillain-Barré syndromes,
Valentin Loser, Alex Vicino, Marie Théaudin   +2 more
doaj   +1 more source

Immunoglobulins to mitigate paraneoplastic Lambert Eaton Myasthenic Syndrome under checkpoint inhibition in Merkel cell carcinoma

Neurological Research and Practice, 2020
Lambert-Eaton myasthenic syndrome (LEMS) is a rare, autoimmune or paraneoplastic condition characterized by muscle weakness and fatigability. In cancer therapy, immune checkpoint inhibitors (ICI) sensitize the immune system for tumor antigens.
Maike F. Dohrn, Ulrike Schöne, Charlotte Küppers, Deborah Christen, Jörg B. Schulz, Burkhard Gess, Simone Tauber   +6 more
doaj   +1 more source